Skip to content

Cold Spray and Helfer Skin Tap for Pain During Infant Vaccination

The Effect of Cold Spray and Helfer Skin Tap Technique Used in Intramuscular Vaccinatıon on Pain Levels

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07779681
Enrollment
120
Registered
2026-08-21
Start date
2026-09-15
Completion date
2027-09-01
Last updated
2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Procedural Pain, Vaccination Pain, Injection Pain

Keywords

Cold spray, Helfer Skin Tap, Infant, Procedural pain, Vaccination

Brief summary

This randomized controlled experimental study aims to evaluate the effects of cold spray and the Helfer Skin Tap technique on pain levels during intramuscular pneumococcal conjugate vaccine administration in 12-month-old infants. Vaccination is one of the most common painful procedures during infancy. Pain experienced during injections may cause distress in infants and anxiety in families. Therefore, simple, safe, non-pharmacological methods that can reduce injection-related pain are important in pediatric nursing and primary health care. The study will be conducted at Çorum Söğütlüevler Family Health Center between March 2026 and March 2027. The study population will consist of 12-month-old infants who attend the family health center for intramuscular pneumococcal conjugate vaccination. A total of 120 infants are planned to be included in the study. Participants will be assigned to one of three groups by stratified block randomization: cold spray group, Helfer Skin Tap group, or control group. Each group will include 40 infants. Infants in the control group will receive routine vaccination without any additional intervention. In the cold spray group, cold spray will be applied to the injection site before vaccination. In the Helfer Skin Tap group, the technique will be applied before and during the injection by gently tapping near the injection site in coordination with needle insertion. Data will be collected using a Child Information Form, an Application Record Form, and the Face, Legs, Activity, Cry, Consolability Pain Scale (FLACC). Pain responses will be evaluated before, during, and after vaccination. Crying duration and physiological parameters such as pulse, oxygen saturation, and body temperature will also be recorded. The findings of this study are expected to contribute to evidence-based pediatric nursing practices by identifying whether cold spray or the Helfer Skin Tap technique is effective in reducing pain during infant vaccination.

Detailed description

Pain during vaccination is a common source of distress for infants and concern for families. Since infants cannot verbally express pain, behavioral pain assessment tools are needed to evaluate their pain responses during painful procedures. Non-pharmacological methods that are simple, low-cost, and easy to apply may help reduce injection-related pain in primary health care settings. This study is designed to compare two non-pharmacological pain management methods, cold spray and the Helfer Skin Tap technique, during intramuscular pneumococcal conjugate vaccine administration in 12-month-old infants. The study will be conducted in a family health center setting, where routine infant vaccinations are performed. Eligible infants will be randomly assigned to one of three groups: a cold spray group, a Helfer Skin Tap group, or a control group. In the control group, infants will receive the routine intramuscular vaccine injection without any additional pain-reducing intervention. In the cold spray group, cold spray will be applied to the injection site before the vaccine injection. In the Helfer Skin Tap group, the researcher will apply rhythmic tapping near the injection area before and during needle insertion according to the technique. Pain will be assessed using the Face, Legs, Activity, Cry, Consolability Pain Scale, known as the FLACC scale. Pain responses will be evaluated before, during, and after the vaccination procedure. Crying duration will also be recorded as an additional behavioral indicator of pain. Physiological parameters, including pulse, oxygen saturation, and body temperature, will be measured before and after the injection. The study aims to determine whether cold spray or the Helfer Skin Tap technique reduces pain compared with routine vaccination practice and whether one method is more effective than the other. The results may provide evidence for pediatric nurses and primary health care professionals on the use of practical non-pharmacological pain management methods during infant vaccination.

Interventions

Cold spray will be applied to the injection site from a distance of 15 cm for 5 seconds before intramuscular pneumococcal conjugate vaccination.

The Helfer Skin Tap technique will be applied before and during intramuscular pneumococcal conjugate vaccination by tapping near the injection site in coordination with needle insertion.

Sponsors

Hitit University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be assigned to one of three parallel groups: cold spray, Helfer Skin Tap, or control. Each participant will receive only the intervention assigned to their group during intramuscular pneumococcal conjugate vaccination. The outcomes will be compared between the three groups.

Eligibility

Sex/Gender
ALL
Age
12 Months to 12 Months
Healthy volunteers
Yes

Inclusion criteria

* Parent or legal guardian has at least primary school education. * Parent or legal guardian agrees for the infant to participate in the study. * The infant is scheduled to receive the pneumococcal conjugate vaccine by - intramuscular injection. * The infant was born between 38 and 42 weeks of gestation. * The infant is 12 months old. * The infant's body weight corresponds to the 50th percentile.

Exclusion criteria

* Parent or legal guardian is illiterate. * The infant was born preterm or postterm. * The infant attends the family health center for a vaccine other than the pneumococcal conjugate vaccine. * The infant has a congenital anomaly, birth asphyxia, or any chronic disease. * The infant received an analgesic medication within at least 4 hours before vaccination.

Design outcomes

Primary

MeasureTime frameDescription
Pain Level During Vaccination Assessed by FLACC ScaleDuring intramuscular pneumococcal conjugate vaccinationPain level will be assessed using the Face, Legs, Activity, Cry, Consolability Pain Scale (FLACC). The FLACC scale evaluates five behavioral categories: face, legs, activity, cry, and consolability. Each category is scored from 0 to 2, and the total score ranges from 0 to 10. Higher scores indicate higher pain levels.

Secondary

MeasureTime frameDescription
Pain Level Before and After Vaccination Assessed by FLACC ScaleBefore vaccination and immediately after vaccinationPain level will be assessed before and after vaccination using the FLACC scale. The total score ranges from 0 to 10, with higher scores indicating higher pain levels.
Crying DurationDuring vaccination and immediately after vaccinationCrying duration will be recorded in seconds using a stopwatch during and after the vaccination procedure. Longer crying duration indicates greater behavioral distress.
Pulse Rate Before and After VaccinationImmediately before and immediately after vaccinationPulse rate will be measured immediately before and immediately after vaccination and recorded in beats per minute (bpm).
Peripheral Oxygen Saturation Before and After VaccinationImmediately before and immediately after vaccinationPeripheral oxygen saturation (SpO₂) will be measured immediately before and immediately after vaccination and recorded as a percentage (%).
Body Temperature Before and After VaccinationImmediately before and immediately after vaccinationBody temperature will be measured immediately before and immediately after vaccination and recorded in degrees Celsius (°C).

Contacts

CONTACTSemra söngüt, Assistant Professor (Dr.)
karacaoglu_semra@hotmail.com+905380938989

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026